Skip to main content
OpenTrials

Clinical trial condition

Estrogen Receptor Positive Breast Cancer

Explore clinical trials studying Estrogen Receptor Positive Breast Cancer. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Estrogen Receptor Positive Breast Cancer trial results

Active, not recruiting

Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

NCT02947685

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +5 more
Locations
  • UCSF San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Baycare Healthcare (Morton Plant Mease) Clearwater, Florida, United States
  • Memorial Healthcare System Hollywood, Florida, United States
View all 106 locations
View Trial Details
Active, not recruiting

Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer

NCT01992952

Conditions
Estrogen Receptor Positive Breast Cancer
Locations
  • Velindre NHS Trust Cardiff, United Kingdom
  • Christie Hospital Manchester, Greater Manchester, United Kingdom
  • Ysbyty Gwynedd Bangor, United Kingdom
  • Clatterbridge Cancer Centre Bebington, United Kingdom
View all 21 locations
View Trial Details
Completed

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

NCT00066690

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
View all 500 locations
View Trial Details
Completed

Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer

NCT02668666

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive Breast Cancer, +8 more
Locations
  • University of Illinois Cancer Center Chicago, Illinois, United States
  • Michigan State University Lansing, Michigan, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer

NCT02216786

Conditions
Estrogen Receptor Positive Breast Cancer
Locations
  • ICO Paul Papin Angers, France
  • Institut Sainte Catherine Avignon, France
  • Antoine Lacassagne Centre De Lutte Contre Le Cancer De Nice Nice, France
  • Hospital Center Private Saint-Grégoire Saint-Grégoire, France
View all 79 locations
View Trial Details

Related conditions